BiO2 Medical Receives $14,000,000 Series D Funding

  • Feed Type
  • Date
    1/7/2016
  • Company Name
    BiO2 Medical
  • Mailing Address
    18618 Tuscany Stone San Antonio, TX 78258 USA
  • Company Description
    BiO2 Medical has created the Angel Catheter to protect critically ill patients from acute Pulmonary Embolism (PE). The innovative design incorporates a retrievable Inferior Vena Cava (IVC) filter, permanently attached to a triple lumen central venous catheter.
  • Website
    http://www.bio2medical.com
  • Transaction Type
    Debt
  • Transaction Amount
    $14,000,000
  • Transaction Round
    Series D
  • Proceeds Purposes
    The financing included a $9m Series D funding round from unnamed backers and a $5m venture debt financing from Oxford Finance LLC (This transaction is structured to initially provide $5 million upon closing, with an option for an additional $3m to be provided upon FDA 510(k) clearance of the Angel Catheter). The company intends to use the funds for the US product launch, the expansion of the US and OUS sales force, incremental R&D projects, and general infrastructure development.
  • M&A Terms
  • Venture Investor
    Oxford Finance
  • Venture Investor
    Undisclosed